Home LiteratureArticle Details
PMID: 9270010 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Evidence that cutaneous carcinogen-initiated epithelial cells from mice are quiescent rather than actively cycling.

Cancer research ·Vol. 57 ·No. 16 ·1997-08-15 ·Pages 3436-43

Morris RJ, Coulter K, Tryson K, Steinberg SR

Abstract

The basal layer of the epidermis and hair follicles is composed of actively cycling, transit-amplifying cells and quiescent cells including stem cells. To determine which population is the target of carcinogenic chemicals, we treated CD-1 female mice topically with 5-fluorouracil (5-FU), an agent known to kill cycling but not quiescent cells, to probe the origin of the neoplastic lesions. We first determined that 5-FU kills cycling cells in the epidermis. Treatment of mice at 59 days of age (when in anagen 1) with topical 5-FU delayed hair regrowth by 10 days compared to vehicle-treated controls, suggesting that 5-FU killed the cells in anagen. Moreover, 5-FU suppressed the usual hyperplastic response of the epidermal cells to treatment with 12-O-tetradecanoylphorbol-13-acetate. 5-FU reduced the number of epidermal basal cells counted in cross-sections of skin and suppressed DNA synthesis. Approximately 50% of mice treated with 5-FU developed, within 1 week of treatment, a sloughing of the epidermis persisting for 3 weeks, followed by complete healing. Despite the evidence of cell killing in the epidermis and lower hair follicles, in a carcinogenesis experiment where 5-FU or vehicle was applied following tumor initiation with 7,12-dimethylbenz[a]anthracene, the papilloma and carcinoma responses were virtually identical whether or not the mice were treated with 5-FU, suggesting that the tumors arose from quiescent, rather than actively cycling, epidermal cells. When 5-FU was applied before initiation, the papilloma but not the carcinoma responses were slightly but significantly reduced relative to controls. These results are consistent with the hypothesis that the quiescent rather than the rapidly proliferating cells are the targets of tumor initiation.

MeSH Terms
9,10-Dimethyl-1,2-benzanthracene Administration, Topical Animals Antimetabolites, Antineoplastic/administration & dosage,pharmacology Carcinogens Cell Division/drug effects Epidermis/drug effects,pathology Female Fluorouracil/administration & dosage,pharmacology Hair Follicle/drug effects,pathology Mice Neoplasms, Experimental/chemically induced,pathology Papilloma/chemically induced,pathology Skin/drug effects,pathology Skin Neoplasms/chemically induced,pathology Tetradecanoylphorbol Acetate/pharmacology
Chemicals
Antimetabolites, Antineoplastic Carcinogens 9,10-Dimethyl-1,2-benzanthracene Tetradecanoylphorbol Acetate Fluorouracil
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Morris R J
The Lankenau Medical Research Center, Wynnewood, Pennsylvania 19096, USA.
Coulter K
Tryson K
Steinberg S R
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
1997-08-15
Pages
3436-43
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Grants
NCI NIH HHS · CA45293 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]